Safety (pt 2):
The second safety issue of note is Breast Implant Associated-Anaplastic Large Cell Lymphoma (BIA-ALCL). While numerous articles have been written on this subject, an article from CHH Health, dated February 7, 2019, was one I found helpful. In the article it mentions that “at least 457 women in the US” have been diagnosed with this condition. And the consensus seems to lean to the condition being more predominant with textured implants. According to the NIH; “Although rare, all cases with adequate history have involved a textured breast implant.” Indications I have seen are that ‘between 1 and 3 million women in the US have breast implants’, but without a valid number of women with textured implants as a basis to calculate risk, I have not been able to determine a risk level.
The risk of breast implant related cancer has been something I have been aware of for many, many years, so it is nothing new.